U.S. Biomedical Innovation Leadership at Risk: New Data Show China Rapidly Closing Gap as Clinical Trials and Manufacturing Migrate Abroad
3 Articles
3 Articles
Trump Admin Moves to Revive American Medical Innovation
Health Secretary Robert F. Kennedy Jr. is calling for the United States to reconfigure its clinical research in order to maintain its status as a leader in the industry. In an opinion piece for Fox News, Kennedy wrote that a recent study found that China “now conducts more early-stage clinical trials than the United States.” In 2025, Chinese companies accounted for “half of global pharmaceutical licensing deal activity. Those trends should conce…
U.S. Biomedical Innovation Leadership at Risk: New Data Show China Rapidly Closing Gap as Clinical Trials and Manufacturing Migrate Abroad
New Cure Innovation Index evidence-based analyses and expert survey find U.S. retains its scientific edge but is losing the race to translate discoveries to cures
US Biomedical Innovation Faces Threat: New Data Reveal China Quickly
The United States currently maintains a leading position over China in the quality and commercial influence of its biomedical research. However, recent evaluations reveal a mounting challenge: while the U.S. demonstrates formidable strength in discovery, it is increasingly falling behind in the critical phase of translation — the process of converting scientific breakthroughs into tangible cures and therapies. This shift threatens the longstandi…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
